CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-17 | Grunberg Gregory Director | Grant or award | +20,000 | 40,000 | ||
| 2020-06-25 | Grunberg Gregory Director | Grant or award | +20,000 | 20,000 | ||
| 2020-03-13 | Grunberg Gregory Director | Purchase | +2,534,854 | $7.89 | $20.0M | 2,534,854 |
| 2019-06-05 | Grunberg Gregory Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | ||
| 2018-10-05 | Grunberg Gregory Director | Purchase | +606,060 | $8.25 | $5.0M | 2,877,006 |
| 2018-06-12 | Grunberg Gregory Director | Grant or award · Stock Option (right to buy) | +12,960 | 12,960 | ||
| 2017-07-25 | Grunberg Gregory Director | Conversion | +2,055,946 | 2,055,946 | ||
| 2017-07-25 | Grunberg Gregory Director | Purchase | +215,000 | $15.00 | $3.2M | 2,270,946 |
| 2017-07-25 | Grunberg Gregory Director | Conversion · Series C Preferred Stock | −10,707,985 | 0 | ||
| 2017-07-19 | Grunberg Gregory Director | Grant or award · Stock Option (right to buy) | +12,960 | 12,960 |
Page 1 of 1 · 10 trades